Showing 1 to 9 of 9 results
Novel Antivenom Developed from Hyper-Immune Man's Blood Shows Promise
Scientists created a highly effective antivenom using antibodies from a man who'd been bitten hundreds of times by venomous snakes; mouse trials showed effectiveness against multiple species, potentially revolutionizing snakebite treatment globally.
Novel Antivenom Developed from Hyper-Immune Man's Blood Shows Promise
Scientists created a highly effective antivenom using antibodies from a man who'd been bitten hundreds of times by venomous snakes; mouse trials showed effectiveness against multiple species, potentially revolutionizing snakebite treatment globally.
Progress
40% Bias Score
Novel Antivenom Shows Broad Protection Against Elapid Snakebites
A novel antivenom, derived from the blood of a man who self-injected snake venom for 18 years, shows unprecedented protection against multiple elapid snake species in animal tests, potentially revolutionizing snakebite treatment and saving the lives of up to 140,000 people annually.
Novel Antivenom Shows Broad Protection Against Elapid Snakebites
A novel antivenom, derived from the blood of a man who self-injected snake venom for 18 years, shows unprecedented protection against multiple elapid snake species in animal tests, potentially revolutionizing snakebite treatment and saving the lives of up to 140,000 people annually.
Progress
40% Bias Score
Snakebite Antivenom Breakthrough from Self-Experimentation
Tim Friede's self-experimentation with snake venom, spanning 18 years, has led to the discovery of two broadly neutralizing antibodies in his blood by Columbia University scientists, potentially revolutionizing antivenom treatment for snakebites affecting 110,000 people annually.
Snakebite Antivenom Breakthrough from Self-Experimentation
Tim Friede's self-experimentation with snake venom, spanning 18 years, has led to the discovery of two broadly neutralizing antibodies in his blood by Columbia University scientists, potentially revolutionizing antivenom treatment for snakebites affecting 110,000 people annually.
Progress
36% Bias Score
Novel Antivenom Shows Promise Against Multiple Elapid Snake Venoms
A new antivenom, created using antibodies from a human who repeatedly exposed himself to snake venom, shows complete protection against 13 elapid snake species in mice and partial protection against 6 others; further testing in dogs is planned.
Novel Antivenom Shows Promise Against Multiple Elapid Snake Venoms
A new antivenom, created using antibodies from a human who repeatedly exposed himself to snake venom, shows complete protection against 13 elapid snake species in mice and partial protection against 6 others; further testing in dogs is planned.
Progress
32% Bias Score
AI-designed treatment shows promise for snakebite envenomation
A team led by Dr. Susana Vázquez used AI to create a new treatment for snakebite envenomation, a neglected tropical disease causing over 100,000 deaths annually; the treatment showed 100% survival rates in mice trials and is published in Nature.
AI-designed treatment shows promise for snakebite envenomation
A team led by Dr. Susana Vázquez used AI to create a new treatment for snakebite envenomation, a neglected tropical disease causing over 100,000 deaths annually; the treatment showed 100% survival rates in mice trials and is published in Nature.
Progress
52% Bias Score
New Broad-Spectrum Antivenom Shows Promise in Mice Trials
Researchers have developed a new broad-spectrum antivenom using antibodies from a volunteer who was repeatedly exposed to various snake venoms; this antivenom showed effectiveness against 19 of the world's deadliest snakes in mice trials, offering a potential solution to the high mortality rates cau...
New Broad-Spectrum Antivenom Shows Promise in Mice Trials
Researchers have developed a new broad-spectrum antivenom using antibodies from a volunteer who was repeatedly exposed to various snake venoms; this antivenom showed effectiveness against 19 of the world's deadliest snakes in mice trials, offering a potential solution to the high mortality rates cau...
Progress
36% Bias Score
Snakebite Antivenom Breakthrough from Self-Experimentation
An American herpetologist, Tim Friede, allowed himself to be bitten by hundreds of venomous snakes to build immunity; his blood yielded two antibodies neutralizing many snake venoms, potentially revolutionizing antivenom treatment, currently costing thousands of lives annually.
Snakebite Antivenom Breakthrough from Self-Experimentation
An American herpetologist, Tim Friede, allowed himself to be bitten by hundreds of venomous snakes to build immunity; his blood yielded two antibodies neutralizing many snake venoms, potentially revolutionizing antivenom treatment, currently costing thousands of lives annually.
Progress
36% Bias Score
Novel Antivenom Developed Using Antibodies from Man Who Self-Administered Snake Venom
Tim Friede's 18-year self-experimentation involving over 850 snake venom doses resulted in a novel, broadly protective antivenom created by scientists using his antibodies; this antivenom offers protection against 13 of 19 deadliest snake species and could revolutionize snakebite treatment globally.
Novel Antivenom Developed Using Antibodies from Man Who Self-Administered Snake Venom
Tim Friede's 18-year self-experimentation involving over 850 snake venom doses resulted in a novel, broadly protective antivenom created by scientists using his antibodies; this antivenom offers protection against 13 of 19 deadliest snake species and could revolutionize snakebite treatment globally.
Progress
40% Bias Score
Broad-Spectrum Antivenom Shows Promise Against Elapid Snake Venom
A novel antivenom, developed using antibodies from a human repeatedly exposed to snake venom, shows complete protection against 13 elapid snake species and partial protection against 6 others in mouse trials; further testing in dogs is planned.
Broad-Spectrum Antivenom Shows Promise Against Elapid Snake Venom
A novel antivenom, developed using antibodies from a human repeatedly exposed to snake venom, shows complete protection against 13 elapid snake species and partial protection against 6 others in mouse trials; further testing in dogs is planned.
Progress
40% Bias Score
Showing 1 to 9 of 9 results